Engineering highly efficient NIR-II FRET platform for Background-Free homogeneous detection of SARS-CoV-2 neutralizing antibodies in whole blood.

Förster or fluorescence resonance energy transfer (FRET) enables to probe biomolecular interactions, thus playing a vital role in bioassays. However, conventional FRET platforms suffer from limited sensitivity due to the low FRET efficiency and poor anti-interference of existing FRET pairs. Here we report a NIR-II (1000-1700 nm) FRET platform with extremely high FRET efficiency and exceptional anti-interference capability. This NIR-II FRET platform is established based on a pair of lanthanides downshifting nanoparticles (DSNPs) by employing Nd3+ doped DSNPs as an energy donor and Yb3+ doped DSNPs as an energy acceptor. The maximum FRET efficiency of this well-engineered NIR-II FRET platform reaches up to 92.2%, which is much higher than most commonly used ones. Owing to the all-NIR advantage (λex = 808 nm, λem = 1064 nm), this highly efficient NIR-II FRET platform exhibits extraordinary anti-interference in whole blood, and thus enabling background-free homogeneous detection of SARS-CoV-2 neutralizing antibodies in clinical whole blood sample with high sensitivity (limit of detection = 0.5 µg/mL) and specificity. This work opens up new opportunities for realizing highly sensitive detection of various biomarkers in biological samples with severe background interference.

Assessment of different laboratory tests for the diagnosis of novel coronavirus infections

Rapid diagnosis of coronavirus disease 2019 (COVID-19)-infected patients is urgent in making decisions on public health measures. There are different types of diagnostic tests, such as quantitative PCR assay, antibody, and antigen-based and CRISPR-based tests, which detect genetic materials, viral proteins, or human antibodies in clinical samples. However, the proper test should be highly sensitive, quick, and affordable to address this life-threatening situation. This review article highlights the advantages and disadvantages of each test and compares its different features, such as sensitivity, specificity, and limit of detection to reach a reliable conclusion. Moreover, the FDA- authorized kits and studies' approaches toward these have been compared to provide a better perspective to the researchers.Copyright © 2022 Lippincott Williams and Wilkins. All rights reserved.

Ln-MOF Based Ratiometric Luminescent Sensor for the Detection of Potential COVID-19 Drugs.

Countless people have been affected by the COVID-19 pandemic on a global scale. Favipiravir, has shown potential as an effective drug for SARS-CoV-2, attracting scientists' attention. However, overuse of Favipiravir easily leads to serious side effects, requiring real-time monitoring in body fluids. Given this, a new lanthanide metal organic framework (MOF) was prepared under solvothermal conditions from either Eu (Eu-MOF or (1)) or Tb (Tb-MOF or (2)) using the highly delocalized imidazoledicarboxylic acid linker H2L (H2L = 5-(4-(imidazol-1-yl) phenyl) isophthalic acid) and could be successfully applied to selective optical detection of Favipiravir. In this MOF framework, the organic linker H2L provides a high excitation energy transfer efficiency that can sensitize luminescence in lanthanides. In addition, through deliberate tuning of Eu/Tb molar ratio and reaction concentration in the lanthanide framework, ratiometric recyclable luminescent EuxTb1-x-MOF nanoparticles with open metal sites have been constructed, which present a high detection sensitivity (Ksv = 1×107 [M-1], detection limit is 4.63 nM) for Favipiravir. The detection mechanism is discussed with the help of Density Functional Theory (DFT) calculations that sheds light over the selective sensing of Favipiravir over other related COVID-19 drug candidates. Finally, to explore the practical application of Favipiravir sensing, MOF based thin films have been used for visual detection of Favipiravir and recycled 5 times.

Multiplexed detection of SARS-CoV-2 based on upconversion luminescence nanoprobe/MXene biosensing platform for COVID-19 point-of-care diagnostics.

Multiplexed detection is essential in biomedical sciences since it is more efficient and accurate than single-analyte detection. For an accurate early diagnosis of COVID-19, a multiplexed detection strategy is required to avoid false negatives with the existing gold standard assay. Nb2CTx nanosheets were found to efficiently quench the fluorescence emission of lanthanide-doped upconversion luminescence nanoparticles at wavelengths ranging from visible to near-infrared spectrum. Using this broad-spectrum quencher, we developed a label-free FRET-based biosensor for rapid and accurate detection of SARS-CoV-2 RNA. To target ORF and N genes, two types of oligo-modified lanthanide-doped upconversion nanoparticles can be used simultaneously to identify-two sites in one assay via upconversion fluorescence enhancement intensity measurement with detection limits of 15 pM and 914 pM, respectively. Moreover, with multisite cross-validation, this multiplexed and sensitive biosensor is capable of simultaneous and multicolor analysis of two gene fragments of SARS-CoV-2 Omicron variant within minutes in a single homogeneous solution, which significantly improves the detection efficiency. The diagnosis result via our assay is consistent with the PCR result, demonstrating its application in the rapid and accurate screening of multiple genes of SARS-CoV-2 and other infectious diseases.

Efficient Near-Infrared Response Antibacterial Ceramics Based on the Method of Facile In Situ Etching Upconversion Glass-Ceramics.

As the world is faced with the coronavirus disease 2019 (COVID-19) pandemic, photocatalytic antibacterial ceramics can reduce the consumption of disinfectants and improve the safety of the public health environment. However, these antibacterial ceramics are often limited by poor stability and low light utilization efficiency. Herein, an antibacterial ceramic was developed via the method of facile in situ etching of upconversion glass-ceramics (UGC) (FIEG) with HCl, in which the BiOCl nanosheets were in situ grown on the surface of GC to improve its stability and antibacterial activity. The results suggest that the upconversion antibacterial ceramics can harvest and utilize near-infrared (NIR) photons efficiently, which display notable antibacterial activity for Escherichia coli (E. coli) under NIR (≥780 nm) and visible light (420-780 nm) irradiation, with a maximum inactivation rate of 7.5 log in 30 min. Meanwhile, in the cycle experiment, more than 6 log inactivation of E. coli was achieved using an antibacterial ceramic sheet after 2-h NIR light irradiation, and the stability of the antibacterial ceramic was discussed. Furthermore, the reactive species, fluorescence-based live/dead cells, and cell structure of bacteria were analyzed to verify the antibacterial mechanism. This study provides a promising strategy for the construction of efficient and stable antibacterial ceramics.

Assessment of bauxite residue as secondary resource for rare earth metal and valorization challenges: A perspective

Bauxite residue (BR), simultaneously an environmental challenge as well as known to be a secondary resource for resources various valuable metals like Ti, V, Ga, and rare earth metal (REM). Lack of understanding and technology detects BR to be stockpiled which is counterproductive considering the environment, land scarcity, and management of BR inventories. As BR remains unexploited, significant amounts of REMs in BR remain unlocked, which are critical metals from green energy, environmental sustainability, and supply chain bottleneck perspective. Our current investigation analyses the potential of BR as secondary resources and quantity and worth of REM being remains unlocked. The quantitative content of global bauxite, alumina, and BR production during the last 5 decades have been analyzed. Also, plausible BR generation in the next 3 decades has been estimated. Considering the content of REM in BR amount of REM either stockpiled or to be stockpiled along with BR has been analyzed. Our study indicated about 9.14 million tons of REM remain locked in the stockpiled BR, 31.24 million tons of REM remain locked in the bauxite reserve. The worth of worldwide REM oxide remains unexploited in bauxite reserves and locked in stockpiled BR could be approximately $5000 billion, potentially can meet current and project demand of REM abundantly.